Preemption, Health and Safety, and the Supreme Court -- Riegel v. Medtronic

On Thursday, November 1, 2007, ACS hosted a panel discussion on the upcoming Supreme Court case, Riegel v. Medtronic, which deals with whether state tort claims are preempted by approval of a medical device by the Food and Drug Administration. Experts from a variety of perspectives presented their views on the case and previewed some of the points likely to be raised when the Supreme Court hears oral argument on December 4th. In addition, panelists discussed preemption doctrine and its application in the health and safety arena.
The panel included:
- David C. Vladeck, Professor, Georgetown University Law Center (Real Video / Windows Media)
- Catherine M. Sharkey, Professor, New York University School of Law (Real Video / Windows Media)
- David C. Frederick, Partner, Kellogg, Huber, Hansen, Todd, Evans & Figel, P.L.L.C. (Real Video / Windows Media)
- Richard A. Samp, Chief Counsel, Washington Legal Foundation (Real Video / Windows Media)
- Moderator, Paul T. Kim, Partner, Foley Hoag L.L.P.
Introduction of speakers on the panel: (Real Video / Windows Media)
Discussion: (Real Video / Windows Media)
Link to questions and answers: (Real Video / Windows Media)

